Positive: Bondholders approve extending maturity dates for Idorsia's convertible bonds, pending further approvals

From GlobeNewswire: 2025-06-25 13:15:00

Idorsia Ltd announced positive outcomes from bondholder meetings for CHF 200 million and CHF 600 million convertible bonds. The meetings resulted in amendments to extend maturity dates to 2034 and 2038, with 89.5% and 93.5% of holders voting in favor, respectively. The amendments are pending approval by the higher cantonal composition authority and are conditional on a repurchase offer. Idorsia aims to challenge medical paradigms and develop transformative medicines, headquartered in Switzerland. For more information, visit www.idorsia.com/CB2025 and www.idorsia.com/CB2028. Contact Investor & Media Relations at +41 58 844 10 10 or [email protected] for further details.



Read more at GlobeNewswire: Bondholders approve amended terms of the 2025 and 2028